William Demant Foundation donates DKK 3.5 million to UNICEF to help fight coronavirus
The coronavirus pandemic has had severe impact on communities around the world. Especially in low-income regions. Coronavirus isn’t just crushing fragile health systems; it significantly affects education systems, health services and results in political instability.
Being founded on care and with world health as its key sustainable goal, William Demant Foundation wish to support UNICEF and partners’ aim to stem and hopefully put an end to the coronavirus pandemic. In 2022, the goal is to deliver four billion COVID-19-vaccine doses and in addition 988 million diagnostic tests as well as to support the treatment of 120 million cases and provision of personal protective equipment for 2.7 million health workers.
“When society becomes unstable and adults become ill, the children and their development opportunities are severely affected, and their needs are not met. With our donation, we want to take part in easing the situation for children, families and healthcare workers in vulnerable communities and do our part in getting the world back on its feet. The most important steps on this path are vaccines and sustainable healthcare infrastructure, and we partner with UNICEF to support just that,” says Chairman Lars Nørby, William Demant Foundation.
“We are so grateful that new partners sign up for the fight against COVID-19. The pandemic remains an unprecedented crisis at an unprecedented scale. The consequences are significant globally, so only together it is possible to achieve the extraordinary. The clearest pathway out of the pandemic is to ensure every country has equal access to the tools to fight COVID-19, slow down transmission and curb its spread – tests, treatments, infection control equipment and of course, life-saving vaccines. No one is safe until everyone is safe,” says Director for Partnerships and Programmes, Susanne Dahl, UNICEF.
The donation is directed at UNICEF as the lead implementing partner of ACT-A, which aims to help low-income areas with:
- In-country delivery of coronavirus vaccines
- Diagnostic tests and related technical assistance
- Oxygen systems and novel and repurposed therapeutics
- Personal protective equipment and supplies for front-line healthcare workers to work safely
- Risk communication and community engagement to promote the COVID-19-vaccines, tests and treatments
About ACT-A
The Access to COVID-19 Tools Accelerator (ACT-A) is a global collaboration that seeks to accelerate equitable access to COVID-19 tests, treatments and vaccines. UNICEF is fundraising for approximately one-fifth of the ACT-A funding gap, currently estimated to be underfinanced by 42%.
About William Demant Foundation
William Demant Foundation is a charitable foundation with the main purpose to secure the business activities in Demant A/S and to donate a share of its net income to charter-defined charitable causes. In the last ten years, the William Demant Foundation has donated more than DKK 1 billion to different purposes. The focus has been on projects that promote research and knowledge in audiology.
For further information:
Trine Kromann-Mikkelsen, Vice President, Corporate Communication & Relations
Mobile +45 23968968, email: trkr@demant.com
Maria Westh, Head of External Communications
Mobile +45 50778664, email: mwesth@unicef.dk
Images
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hearing. We create life-changing differences through hearing health.
Subscribe to releases from Demant A/S
Subscribe to all the latest releases from Demant A/S by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Demant A/S
Demant acquires the Danish chain of hearing care clinics Dansk HøreCenter20.8.2024 10:30:00 CEST | Pressemeddelelse
[in Danish below] With the acquisition of Dansk HøreCenter, Demant significantly expands its footprint on the Danish hearing care market, enabling Demant’s Danish hearing care entity Audika to help even more people hear better.
Demant’s climate targets get the green light3.8.2023 08:13:15 CEST | Press release
[in Danish below] Demant’s emission reduction targets have been approved by the Science Based Targets initiative: The Group commits to reducing aggregate scope 1 and 2 emissions by 46% and reducing scope 3 emissions by 46% by 2030 from a 2019 base year and to reaching net-zero emissions across the value chain by 2050.
Demant sets ambitious 2025 target for renewable electricity7.2.2023 08:17:09 CET | Pressemeddelelse
To deliver on its commitment to reduce scope 1 and 2 emissions with 50% in 2030 and ultimately reaching net zero in 2050, the hearing healthcare and audio technology company Demant now publishes a short-term goal of 50% renewable electricity in 2025. On site solar panels are part of the solution.
CEO, Søren Nielsen celebrates his 25-year anniversary with Demant on 1 September 202028.8.2020 14:48:00 CEST | Press release
25 years as ambassador for hearing health
Koncernchef Søren Nielsen har 25-års jubilæum hos Demant den 1. september 202028.8.2020 14:48:00 CEST | Pressemeddelelse
25 år som ambassadør for høresundhed
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom